Global GPCR-targeting Drug Market Research Report 2024(Status and Outlook)

Global GPCR-targeting Drug Market Research Report 2024(Status and Outlook)



Report Overview:

GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.

The Global GPCR-targeting Drug Market Size was estimated at USD 416.91 million in 2023 and is projected to reach USD 486.32 million by 2029, exhibiting a CAGR of 2.60% during the forecast period.

This report provides a deep insight into the global GPCR-targeting Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global GPCR-targeting Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GPCR-targeting Drug market in any manner.

Global GPCR-targeting Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

PerkinElmer

Thermo Fisher Scientific

Merck

BD Biosciences

Molecular Devices

Promega

Qiagen

Abcam

Corning

Discoverx

Cisbio

Market Segmentation (by Type)

Reagent Test Kit

Substrate

Market Segmentation (by Application)

Oncology

Cardiovascular

Central Nervous

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the GPCR-targeting Drug Market

Overview of the regional outlook of the GPCR-targeting Drug Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the GPCR-targeting Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of GPCR-targeting Drug
1.2 Key Market Segments
1.2.1 GPCR-targeting Drug Segment by Type
1.2.2 GPCR-targeting Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GPCR-targeting Drug Market Overview
2.1 Global Market Overview
2.1.1 Global GPCR-targeting Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global GPCR-targeting Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GPCR-targeting Drug Market Competitive Landscape
3.1 Global GPCR-targeting Drug Sales by Manufacturers (2019-2024)
3.2 Global GPCR-targeting Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 GPCR-targeting Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global GPCR-targeting Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers GPCR-targeting Drug Sales Sites, Area Served, Product Type
3.6 GPCR-targeting Drug Market Competitive Situation and Trends
3.6.1 GPCR-targeting Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest GPCR-targeting Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GPCR-targeting Drug Industry Chain Analysis
4.1 GPCR-targeting Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of GPCR-targeting Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GPCR-targeting Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global GPCR-targeting Drug Sales Market Share by Type (2019-2024)
6.3 Global GPCR-targeting Drug Market Size Market Share by Type (2019-2024)
6.4 Global GPCR-targeting Drug Price by Type (2019-2024)
7 GPCR-targeting Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global GPCR-targeting Drug Market Sales by Application (2019-2024)
7.3 Global GPCR-targeting Drug Market Size (M USD) by Application (2019-2024)
7.4 Global GPCR-targeting Drug Sales Growth Rate by Application (2019-2024)
8 GPCR-targeting Drug Market Segmentation by Region
8.1 Global GPCR-targeting Drug Sales by Region
8.1.1 Global GPCR-targeting Drug Sales by Region
8.1.2 Global GPCR-targeting Drug Sales Market Share by Region
8.2 North America
8.2.1 North America GPCR-targeting Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe GPCR-targeting Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific GPCR-targeting Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America GPCR-targeting Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa GPCR-targeting Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 PerkinElmer
9.1.1 PerkinElmer GPCR-targeting Drug Basic Information
9.1.2 PerkinElmer GPCR-targeting Drug Product Overview
9.1.3 PerkinElmer GPCR-targeting Drug Product Market Performance
9.1.4 PerkinElmer Business Overview
9.1.5 PerkinElmer GPCR-targeting Drug SWOT Analysis
9.1.6 PerkinElmer Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific GPCR-targeting Drug Basic Information
9.2.2 Thermo Fisher Scientific GPCR-targeting Drug Product Overview
9.2.3 Thermo Fisher Scientific GPCR-targeting Drug Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific GPCR-targeting Drug SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 Merck
9.3.1 Merck GPCR-targeting Drug Basic Information
9.3.2 Merck GPCR-targeting Drug Product Overview
9.3.3 Merck GPCR-targeting Drug Product Market Performance
9.3.4 Merck GPCR-targeting Drug SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 BD Biosciences
9.4.1 BD Biosciences GPCR-targeting Drug Basic Information
9.4.2 BD Biosciences GPCR-targeting Drug Product Overview
9.4.3 BD Biosciences GPCR-targeting Drug Product Market Performance
9.4.4 BD Biosciences Business Overview
9.4.5 BD Biosciences Recent Developments
9.5 Molecular Devices
9.5.1 Molecular Devices GPCR-targeting Drug Basic Information
9.5.2 Molecular Devices GPCR-targeting Drug Product Overview
9.5.3 Molecular Devices GPCR-targeting Drug Product Market Performance
9.5.4 Molecular Devices Business Overview
9.5.5 Molecular Devices Recent Developments
9.6 Promega
9.6.1 Promega GPCR-targeting Drug Basic Information
9.6.2 Promega GPCR-targeting Drug Product Overview
9.6.3 Promega GPCR-targeting Drug Product Market Performance
9.6.4 Promega Business Overview
9.6.5 Promega Recent Developments
9.7 Qiagen
9.7.1 Qiagen GPCR-targeting Drug Basic Information
9.7.2 Qiagen GPCR-targeting Drug Product Overview
9.7.3 Qiagen GPCR-targeting Drug Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Abcam
9.8.1 Abcam GPCR-targeting Drug Basic Information
9.8.2 Abcam GPCR-targeting Drug Product Overview
9.8.3 Abcam GPCR-targeting Drug Product Market Performance
9.8.4 Abcam Business Overview
9.8.5 Abcam Recent Developments
9.9 Corning
9.9.1 Corning GPCR-targeting Drug Basic Information
9.9.2 Corning GPCR-targeting Drug Product Overview
9.9.3 Corning GPCR-targeting Drug Product Market Performance
9.9.4 Corning Business Overview
9.9.5 Corning Recent Developments
9.10 Discoverx
9.10.1 Discoverx GPCR-targeting Drug Basic Information
9.10.2 Discoverx GPCR-targeting Drug Product Overview
9.10.3 Discoverx GPCR-targeting Drug Product Market Performance
9.10.4 Discoverx Business Overview
9.10.5 Discoverx Recent Developments
9.11 Cisbio
9.11.1 Cisbio GPCR-targeting Drug Basic Information
9.11.2 Cisbio GPCR-targeting Drug Product Overview
9.11.3 Cisbio GPCR-targeting Drug Product Market Performance
9.11.4 Cisbio Business Overview
9.11.5 Cisbio Recent Developments
10 GPCR-targeting Drug Market Forecast by Region
10.1 Global GPCR-targeting Drug Market Size Forecast
10.2 Global GPCR-targeting Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe GPCR-targeting Drug Market Size Forecast by Country
10.2.3 Asia Pacific GPCR-targeting Drug Market Size Forecast by Region
10.2.4 South America GPCR-targeting Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of GPCR-targeting Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global GPCR-targeting Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of GPCR-targeting Drug by Type (2025-2030)
11.1.2 Global GPCR-targeting Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of GPCR-targeting Drug by Type (2025-2030)
11.2 Global GPCR-targeting Drug Market Forecast by Application (2025-2030)
11.2.1 Global GPCR-targeting Drug Sales (K Units) Forecast by Application
11.2.2 Global GPCR-targeting Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings